Nanjing Superyears Gene Technology

21/02/2024

Nanjing Superyears is proud to have participated in MEDlab 2024, the largest medical laboratory exhibition in the Middle East . The event, held annually in Dubai, brings together laboratory professionals and suppliers from around the world.
Superyears had the opportunity to engage with hundreds of potential customers from over 70 countries and regions during the exhibition. We showcased our latest gene sequencing device, which received significant attention and interest from attendees.
We also actively participated in various seminars and conferences, sharing our insights on the latest advancements in gene sequencing technology and engaging in thought-provoking discussions with industry experts and scholars.
We are confident that this participation will have a positive impact on our company's future growth.

06/02/2024

We were delighted to host our customers at our facility today. We showed them how our gene sequencers are made and demonstrated how they work.
Our customers were very interested in our facility. They were impressed by the advanced technology we use and our strict quality requirements. They were also excited about how our gene sequencers can help doctors diagnose diseases and develop new therapies.
We are grateful for the opportunity to share our gene sequencing technology and help our customers understand how we are contributing to the healthcare industry.
sequencer sequencing technology industry diagnosis therapies

25/01/2024

Glycosyl groups are carbohydrate derivatives formed by the condensation of a monosaccharide or oligosaccharide with another non-carbohydrate compound or functional group through a glycosidic bond. Glycosidic bonds are formed by the condensation of a hydroxyl group on a sugar molecule with an active hydrogen atom or group on another compound.

Glycosyl groups play important roles in biological systems, participating in many aspects of life. Therefore, studying the structure, function, and synthesis of glycosyl groups can help us better understand life.

Superyears Gene is committed to decoding life through glycomics.

11/01/2024

Excitement is building as we gear up for MedLab Middle East 2024.As we prepare to showcase our innovative solutions, we invite you to be a part of this transformative experience. Follow our journey as we lead up to the event, sharing insights, sneak peeks, and more!

30/12/2023

As we step into 2024 we're thrilled to continue our mission: making every genetic experiment easy. The past year has been a journey of innovation and breakthroughs, and we're excited to build on that momentum.

A huge shoutout to our incredible team and partners who have been instrumental in our success. Together, we've simplified the complexities of genetic research, paving the way for a future where experimentation is seamless and accessible.

Here's to another year of collaboration, discovery, and pushing the boundaries of what's possible. Let's make 2024 a year of even greater strides in genetic innovation!

Wishing you joy, success, and exciting discoveries in the coming year. Cheers to a brilliant 2024! 🚀✨

12/12/2023

We take pride in contributing to the forefront of scientific exploration. Our state-of-the-art Sanger DNA sequencing machines have been instrumental in supporting a recent study conducted by a dedicated team of scientists.

DNA profiling of short tandem repeats (STRs) is the primary method for genotyping forensic samples. However, degraded DNA and trace samples are still major problems for commercial 5- or 6-dye STR kits. In order to improve the performance of this method, we developed a novel 8-dye STR multiplex syste...

01/12/2023

Gene sequencing plays an extremely critical role in the detection of HIV drug resistance genotypes. Based on the Sanger sequencing platform, which is the "gold standard" for gene sequencing, we are able to accurately sequence the nucleic acid sequence of the HIV virus in a relatively short period of time to detect mutations in the drug resistance locus and test for viral genotypes, so that we can adjust the ART regimen in time to provide faster, more accurate and more comprehensive scientific guidance for the detection of drug resistance and treatment of AIDS. This will provide faster, more accurate and more comprehensive scientific guidance for the detection and treatment of drug resistance, and help achieve scientific treatment of AIDS.

27/11/2023

https://www.linkedin.com/feed/update/urn:li:activity:7133366183872929793

14/11/2023

Exciting News! We're thrilled to announce our presence at MEDICA 2023, the world's leading medical trade fair. We have brought our DNA sequencing machine. Moreover we want to share with you more information about the medical diagnostics .See you in our booth !

10/11/2023

We're thrilled to share our recent experience at the Chongqing International Laboratory Medicine and In Vitro Diagnostic Reagent Exhibition. It was an incredible opportunity to connect with fellow professionals and showcase our latest innovations.

Our booth was buzzing with enthusiasm as attendees explored our cutting-edge products, asked questions, and shared their insights. The passion and dedication in the room were truly inspiring.

We're committed to advancing the field of laboratory medicine and in vitro diagnostics, and your support fuels our drive. Whether you had the chance to visit us at the exhibition or not, we're here to answer your questions and provide information about our products. The future of healthcare is bright, and we're excited to be a part of it.

Stay tuned for more updates, and don't hesitate to reach out. Together, we're shaping the future of lab medicine.

02/11/2023

Dr Erdmann Rapp， CEO of GlyXera and Prof Wang Wei，Pro-vice of Chancellor of EDU, visited Suyuan Genentech, visited the factory in Pukou District, Nanjing, and at the same time, visited the production process of our gene sequencers and related parts, and had an in-depth discussion on related technical issues. The visit reached a consensus that both parties will carry out technical exchanges and cooperative research and development in the subsequent cooperation.